Cubist Pharma Reports Q3 Non-GAAP EPS Of $0.58 - Quick Facts

(RTTNews) - Cubist Pharmaceuticals Inc. (CBST) reported third-quarter net income of $22.83 million or $0.29 per share, compared to a loss of $33.90 million or $0.50 per share, previous year. Non-GAAP net income was $52.41 million or $0.58 per share, for the quarter .

On average, 11 analysts polled by Thomson Reuters expected the company to report profit per share of $0.04 for the quarter. Analysts' estimates typically exclude special items.

Total revenues, net increased to $309.16 million from $265.99 million, last year. Analysts expected revenue of $306.75 million for the quarter. "This was a strong quarter for Cubist in which we made significant progress against our 2014 financial and business objectives, driven by CUBICIN and meaningful contributions across our portfolio," said Mike Bonney, CEO of Cubist.